Cirius Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Cirius Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH (NCT03970031) | Cirius Therapeutics, Inc. | 2022-06-01 |
Track Cirius Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.